Genes | ESBL | non-ESBL | OR (95% CI)c | p-valued |
---|---|---|---|---|
blaOXAa | ||||
 OXA-neg | 406 | 458 |  |  |
 OXA-pos | 674 | 604 | 1.3 (1.1–1.5) | 0.009 |
blaCTXMb | ||||
 CTXM-neg | 112 | 660 |  |  |
 CTXM-pos | 968 | 401 | 14.2 (11.2–18.1) | < 0.001 |
blaTEM | ||||
 TEM-neg | 262 | 517 |  |  |
 TEM-pos | 818 | 545 | 3.0 (2.5–3.6) | < 0.001 |
Genes | MDR | non-MDR | OR (95% CI)c | p-valued |
---|---|---|---|---|
blaOXAa | ||||
 OXA-neg | 751 | 113 |  |  |
 OXA-pos | 1198 | 80 | 2.3( 1.7–3.1) | < 0.001 |
blaCTXMb | ||||
 CTXM-neg | 629 | 143 |  |  |
 CTXM-pos | 1319 | 50 | 6.0 ( 4.2–8.6) | < 0.001 |
blaTEM | ||||
 TEM-neg | 680 | 99 |  |  |
 TEM-pos | 1269 | 94 | 2.0 ( 1.4–2.7) | < 0.001 |
Genes | Cephal. ¾ non-susceptible | Cephal. ¾ susceptible | OR (95% CI)c | p-valued |
---|---|---|---|---|
blaOXAa | ||||
 OXA-neg | 825 | 35 |  |  |
 OXA-pos | 1244 | 26 | 2.0 ( 1.2–3.5) | 0.008 |
blaCTXMb | ||||
 CTXM-neg | 710 | 54 |  |  |
 CTXM-pos | 1358 | 7 | 14.7 ( 6.6–38.6) | < 0.001 |
blaTEM | ||||
 TEM-neg | 746 | 27 |  |  |
 TEM-pos | 1323 | 34 | 1.4 (0.8–2.4) | 0.22 |